Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report

Authors

  • Edi William Aguilar-Urbina Especialista en Enfermedades Infecciosas y Doctor en medicina https://orcid.org/0000-0001-6510-5346
  • Carlos Plasencia-Meza Especialista en Medicina interna, Magister en medicina https://orcid.org/0000-0001-6510-5346
  • Manuel Chávez-Rimarachin Especialista en Medicina interna, Magister en medicina https://orcid.org/0000-0003-1229-0036
  • Regina Aquino-Salverredy Especialista en Medicina interna, Magister en medicina
  • Anghelo Velásquez-Ojeda Especialista en Nefrología

DOI:

https://doi.org/10.35434/rcmhnaaa.2021.143.1280

Keywords:

Bullous pigmented fixed erythema, toxicoderma, drug erythema pigmentation

Abstract

Background: Bullous fixed pigmented erythema is a potentially serious form of toxicoderma. It is characterized by the appearance of cutaneous and / or mucosal lesions, single or multiple, which can appear in any area, after the administration of a drug or other substance. A 73-year-old man is presented with a diagnosis of bullous fixed pigmented erythema secondary to the ingestion of ivermectin. It is necessary for the physician to recognize the adverse effects of self-medication with ivermectin against SARS CoV-2, to make an early diagnosis and initiate timely treatment.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Edi William Aguilar-Urbina, Especialista en Enfermedades Infecciosas y Doctor en medicina

  1. Hospital Regional Docente de Trujillo, La Libertad, Perú.
  2. Universidad Nacional de Trujillo, La Libertad, Perú.

Carlos Plasencia-Meza, Especialista en Medicina interna, Magister en medicina

  1. Hospital Regional Docente de Trujillo, La Libertad, Perú.
  2. Universidad Nacional de Trujillo, La Libertad, Perú.

Manuel Chávez-Rimarachin, Especialista en Medicina interna, Magister en medicina

  1. Hospital Regional Docente de Trujillo, La Libertad, Perú.
  2. Universidad Antenor Orrego, La Libertad, Perú.

Regina Aquino-Salverredy, Especialista en Medicina interna, Magister en medicina

  1. Hospital Regional Docente de Trujillo, La Libertad, Perú.
  2. Universidad Nacional de Trujillo, La Libertad, Perú.

Anghelo Velásquez-Ojeda, Especialista en Nefrología

  1. Hospital Regional Docente de Trujillo, La Libertad, Perú.

Published

2021-12-16

How to Cite

1.
Aguilar-Urbina EW, Plasencia-Meza C, Chávez-Rimarachin M, Aquino-Salverredy R, Velásquez-Ojeda A. Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report. Rev. Cuerpo Med. HNAAA [Internet]. 2021 Dec. 16 [cited 2024 May 15];14(3):394-7. Available from: http://www.cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1280

Recommended Articles